Freedman RS - Search Results

1

Intraperitoneal fluid neopterin, nitrate, and tryptophan after regional administration of interleukin-12.

Melichar B, Lenzi R, Rosenblum M, Kudelka AP, Kavanagh JJ, Melicharova K, Templin S, Garcia ME, Abbruzzese JL, Freedman RS. Melichar B, et al. Among authors: freedman rs. J Immunother. 2003 May-Jun;26(3):270-6. doi: 10.1097/00002371-200305000-00010. J Immunother. 2003. PMID: 12806280 Clinical Trial.

2

Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trial.

Freedman RS, Edwards CL, Kavanagh JJ, Kudelka AP, Katz RL, Carrasco CH, Atkinson EN, Scott W, Tomasovic B, Templin S, et al. Freedman RS, et al. J Immunother Emphasis Tumor Immunol. 1994 Oct;16(3):198-210. doi: 10.1097/00002371-199410000-00004. J Immunother Emphasis Tumor Immunol. 1994. PMID: 7834119 Clinical Trial.

3

Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.

Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD. Freedman RS, et al. Clin Cancer Res. 2000 Jun;6(6):2268-78. Clin Cancer Res. 2000. PMID: 10873077 Clinical Trial.

4

Phenotype and antitumor activity of ascitic fluid monocytes in patients with ovarian carcinoma.

Melichar B, Savary CA, Patenia R, Templin S, Melicharova K, Freedman RS. Melichar B, et al. Among authors: freedman rs. Int J Gynecol Cancer. 2003 Jul-Aug;13(4):435-43. doi: 10.1046/j.1525-1438.2003.13331.x. Int J Gynecol Cancer. 2003. PMID: 12911719

5

Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.

Lenzi R, Rosenblum M, Verschraegen C, Kudelka AP, Kavanagh JJ, Hicks ME, Lang EA, Nash MA, Levy LB, Garcia ME, Platsoucas CD, Abbruzzese JL, Freedman RS. Lenzi R, et al. Among authors: freedman rs. Clin Cancer Res. 2002 Dec;8(12):3686-95. Clin Cancer Res. 2002. PMID: 12473577 Clinical Trial.

6

Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma.

Lenzi R, Edwards R, June C, Seiden MV, Garcia ME, Rosenblum M, Freedman RS. Lenzi R, et al. Among authors: freedman rs. J Transl Med. 2007 Dec 12;5:66. doi: 10.1186/1479-5876-5-66. J Transl Med. 2007. PMID: 18076766 Free PMC article. Clinical Trial.

7

Effects of interleukin-1 alpha on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancer.

Vadhan-Raj S, Kudelka AP, Garrison L, Gano J, Edwards CL, Freedman RS, Kavanagh JJ. Vadhan-Raj S, et al. Among authors: freedman rs. J Clin Oncol. 1994 Apr;12(4):707-14. doi: 10.1200/JCO.1994.12.4.707. J Clin Oncol. 1994. PMID: 8151314 Clinical Trial.

8

Paclitaxel in patients with platinum-resistant ovarian cancer: a selected review of literature and clinical experience.

Kudelka AP, Tresukosol D, Gonzalez de Leon C, Termrungruanglert W, Edwards CL, Freedman RS, Tornos C, Kavanagh JJ. Kudelka AP, et al. Among authors: freedman rs. J Med Assoc Thai. 1996 Apr;79(4):240-5. J Med Assoc Thai. 1996. PMID: 8708510 Review.

9

Effects of interleukin-1 alpha on ovarian carcinoma in patients with recurrent disease.

Verschraegen CF, Kudelka AP, Termrungruanglert W, de Leon CG, Edwards CL, Freedman RS, Kavanagh JJ, Vadhan-Raj S. Verschraegen CF, et al. Among authors: freedman rs. Eur J Cancer. 1996 Aug;32A(9):1609-11. doi: 10.1016/0959-8049(96)00108-6. Eur J Cancer. 1996. PMID: 8911126 Clinical Trial.

10

Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinoma.

Freedman RS, Gibbons JA, Giedlin M, Kudelka AP, Kavanagh JJ, Edwards CL, Carrasco CH, Nash MA, Platsoucas CD. Freedman RS, et al. J Immunother Emphasis Tumor Immunol. 1996 Nov;19(6):443-51. doi: 10.1097/00002371-199611000-00009. J Immunother Emphasis Tumor Immunol. 1996. PMID: 9041464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters